University of Alabama at Birmingham: Carcinoma trials

The registry lists 12 Carcinoma studies with University of Alabama at Birmingham as lead sponsor. 1 are open to participants now and 8 have results posted.

Early Phase 1 1Phase 1 4Phase 2 8No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cabozantinib and Dostarlimab in Recurrent Gynecologic CarcinosarcomaRecruitingNCT05559879Phase 1/2
• [68Ga]DOTATATE-PET/MRI in Hepatocellular CarcinomaCompletedNCT03648073Phase 1/2Results posted
• Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) ImagingTerminatedNCT03303469Phase 2Results posted
• Trial of Pembrolizumab for Advanced Penile Squamous Cell CarcinomaTerminatedNCT02837042Phase 2Results posted
• Trial Using Gilotrif for Advanced Penile Squamous Cell CarcinomaTerminatedNCT02541903Phase 2Results posted
• A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular CarcinomaCompletedNCT01247298Early Phase 1Results posted
• Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular CarcinomaTerminatedNCT01005875Not applicableResults posted
• Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With CelecoxibCompletedNCT00582660Phase 2Results posted
• A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell CarcinomaCompletedNCT00369512Phase 2Results posted
• Study of Nintedanib Plus Bevacizumab in Advanced Solid TumorsCompletedNCT02835833Phase 1
• Effects of Diet and Exercise on Ductal Carcinoma in SituCompletedNCT02224807Not applicable
• Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and NeckCompletedNCT00318890Phase 1/2